BRSHF — Bruush Oral Care Income Statement
0.000.00%
Consumer CyclicalsHighly SpeculativeMicro Cap
- $0.03m
- $2.17m
- $2.63m
Annual income statement for Bruush Oral Care, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
| 2020 January 31st | 2021 January 31st | 2022 October 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 
| Source: | PROSPECTUS | PROSPECTUS | 20-F | 
| Standards: | IFRS | IFRS | IFRS | 
| Status: | Final | Final | Final | 
| Revenue | |||
| Total Revenue | 0.207 | 0.901 | 2.63 | 
| Cost of Revenue | |||
| Gross Profit | 0.141 | 0.61 | 1.81 | 
| Selling / General / Administrative Expenses | |||
| Research And Development | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Total Operating Expenses | 1.58 | 9.25 | 14.1 | 
| Operating Profit | -1.38 | -8.35 | -11.5 | 
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -1.38 | -8.89 | -8.77 | 
| Net Income After Taxes | -1.38 | -8.89 | -8.77 | 
| Net Income Before Extraordinary Items | |||
| Net Income | -1.38 | -8.89 | -8.77 | 
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -1.38 | -8.89 | -8.77 | 
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -4.23 | -27.3 | -26.9 | 
| Dividends per Share |